Dr. Iqbal has over 25 years of industry experience in leadership and senior management positions in several large and midsize pharma  and biotech companies including Roche, Squib, J&J, West and KBI Bio. Dr. Iqbal is a key member of the senior management team at  SL Pharma Labs. He is a recognized leader and has an overall responsibility for all strategic and operational aspects, including but not limited to formulation development, drug delivery systems, biotechnology development, clinical and commercial manufacturing of a variety  of dosage forms notably, parenterals, intranasals, ophthalmics, topicals as well as novel drug delivery systems. Dr. Iqbal’s deep knowledge and broad expertise covers CMC development aspects of both small and large molecules (both peptides and proteins) utilizing novel technologies such as liposomes, micro-emulsions, co-solvents and nano particles. His expertise in the development of parenterals is especially noteworthy. Dr. Iqbal is also responsible for the ongoing expansion of biotechnology development function and services provided by SL Pharma. He is a great resource for solving complex technical problems. Dr. Iqbal has a Ph.D. in Pharmaceutics from the University of Sciences of Philadelphia. Dr. Iqbal has over 25 years of industry experience in leadership and senior management positions in several large and midsize pharma  and biotech companies including Roche, Squib, J&J, West and KBI Bio. Dr. Iqbal is a key member of the senior management team at  SL Pharma Labs. He is a recognized leader and has an overall responsibility for all strategic and operational aspects, including but not limited to formulation development, drug delivery systems, biotechnology development, clinical and commercial manufacturing of a variety  of dosage forms notably, parenterals, intranasals, ophthalmics, topicals as well as novel drug delivery systems. Dr. Iqbal’s deep knowledge and broad expertise covers CMC development aspects of both small and large molecules (both peptides and proteins) utilizing novel technologies such as liposomes, micro-emulsions, co-solvents and nano particles. His expertise in the development of parenterals is especially noteworthy. Dr. Iqbal is also responsible for the ongoing expansion of biotechnology development function and services provided by SL Pharma. He is a great resource for solving complex technical problems. Dr. Iqbal has a Ph.D. in Pharmaceutics from the University of Sciences of Philadelphia.

hepatology